The following was received from the Commonwealth of Pennsylvania:
On August 25, 2016, the Department [Commonwealth of Pennsylvania] was notified by Lancaster General Hospital that a package was received in which 5 of the 6 sides exceeded the contamination limits in 10 CFR 71.47. This is reportable per 10 CFR 20.1906(d)(1).
A package containing a vial of 5 milliCuries of iodine-123 in liquid form was received from GE Healthcare at approximately 0830 [EDT] this morning. The package was undamaged. The receipt survey was performed and noted removable contamination as follows: Front and handle 10,108 dpm; Right side 2,131 dpm; Front handle 4,977 dpm; Front 4,426 dpm; Top background; Top strap 4,577 dpm; Back/bottom 1,997 dpm.
After completing wipe testing, the technologist performed an area survey. The area background was found to be 0.04 mR/hr. At 1 meter, the package was found to be 0.05 mR/hr. At the package surface the reading was found to be 0.4 mR/hr. The contamination identified as technetium-99m. Given this finding, package [was] opened to verify it was I-123. The contamination is believed to have been transferred from somewhere else. Upon return to the originator (GE) pharmacy, a survey of the delivery driver's hands, vehicle, and all packages in the vehicle was performed. None showed contamination. All hospital personnel involved and surrounding areas were surveyed and found to be contamination free. No one received a dose above regulatory limits.
Cause of the event is unknown at this time. The Department has an inspector onsite. More information will be provided when available.
Event Report ID No: PA160023